Kiwi biotech Aroa Biosurgery gets 'shot in the arm' from investment in US partner

Tela Bio has up to $US25 million to scale sales and clinical trials of Kiwi-developed regenerative tissue technology.
 

Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login